EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and Validation of a New Online Tool for Monitoring Clinical Signs of Canine Atopic Dermatitis

Naomi Harvey iD, Adrian Watson iD, Jeremy Laxalde iD, Gary England iD, Debbie Gow iD

Veterinary Dermatology · 23.10.2026

DOI: 10.1111/vde.70133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Dermatology, online erschienen am 23.10.2026. Verfasst von Naomi Harvey und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Science, The University of Nottingham, Loughborough, Leicestershire, UK. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Canin, University of Nottingham.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of the study was to develop a simple, reliable and validated patient‐reported outcome tool for use in monitoring the severity of clinical signs in dogs with confirmed or suspected atopic allergies and recurrent otitis externa. The tool is called the Dog‐Orientated Severity of Atopy Scale (DOSAS). Materials and Methods The human Patient‐Oriented Eczema Measure (POEM) was adapted for relevance to the owner‐observable clinical signs of canine atopic dermatitis (cAD). Refinements were made via consultation with dog owners and veterinary surgeons to ensure applicability and ease of use. Relevant features of reliability (including internal consistency, intrarater reliability and test–retest reliability) were evaluated. The tool was then tested by owners and clinicians for performance against established clinical sign assessment methods.

Results

The DOSAS was shown to be both reliable and valid with psychometric properties above acceptable guidelines for the development of such tools. Guidelines are presented for score creation and stratification of the score to enable interpretation. When compared to how severity assessment scores from Canine Atopic Dermatitis Extent and Severity Index, 4th iteration (CADESI‐04) and pruritus Visual Assessment Scale (PVAS) responded to change, the DOSAS performed particularly strongly, although it performed less well when compared to the 0–3 Otitis Index Score (OTIS‐3). Conclusions and Clinical Relevance The DOSAS is presented as a supplementary tool for use in veterinary practice and clinical research programmes alongside existing clinical measurements such as CADESI‐04, providing a focus on the disease as it is experienced by the dog and their owner. Unlike clinical measurement, the DOSAS is accessible and interpretable for dog owners, which is important for the management of chronic pruritic conditions, and will enable dog owners to be more actively involved with their dog's disease management.

Autor:innen und Institutionen

  • School of Veterinary Medicine and Science, The University of Nottingham, Loughborough, Leicestershire, UK.
  • Royal Canin SAS, Research and Development, Aimargues, France.
  • Vet Specialists Scotland, Livingston, West Lothian, UK.

ORCID-Profile: Naomi Harvey, Adrian Watson, Jeremy Laxalde, Gary England, Debbie Gow

Förderung

  • Royal Canin
  • University of Nottingham

Zitieren

APA

Harvey, N., Watson, A., Laxalde, J., England, G., & Gow, D. (2026). Development and Validation of a New Online Tool for Monitoring Clinical Signs of Canine Atopic Dermatitis. Veterinary Dermatology. https://doi.org/10.1111/vde.70133

Vancouver

Harvey N, Watson A, Laxalde J, England G, Gow D. Development and Validation of a New Online Tool for Monitoring Clinical Signs of Canine Atopic Dermatitis. Veterinary Dermatology. 2026. doi:10.1111/vde.70133

BibTeX
@article{Harvey2026,
  author = {Harvey, Naomi and Watson, Adrian and Laxalde, Jeremy and England, Gary and Gow, Debbie},
  title = {Development and Validation of a New Online Tool for Monitoring Clinical Signs of Canine Atopic Dermatitis},
  journal = {Veterinary Dermatology},
  year = {2026},
  doi = {10.1111/vde.70133}
}
Kostenlos starten →